Telo Genomics Corp.
TDSGF
$0.07
$0.0057.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 68.53% | -52.12% | -40.52% | -48.20% | -32.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.98% | -26.01% | -19.20% | -31.20% | -13.07% |
| Operating Income | -28.98% | 26.01% | 19.20% | 31.20% | 13.07% |
| Income Before Tax | -31.01% | 28.52% | 19.17% | 31.19% | 14.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.01% | 28.52% | 19.17% | 31.19% | 14.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.01% | 28.52% | 19.17% | 31.19% | 14.48% |
| EBIT | -28.98% | 26.01% | 19.20% | 31.20% | 13.07% |
| EBITDA | -30.63% | 25.44% | 18.73% | 31.40% | 13.36% |
| EPS Basic | 6.35% | 33.72% | 22.86% | 40.78% | 28.41% |
| Normalized Basic EPS | 7.50% | 33.33% | 22.73% | 40.63% | 27.27% |
| EPS Diluted | -11.11% | 17.44% | 2.67% | 40.78% | 28.41% |
| Normalized Diluted EPS | 7.50% | 33.33% | 22.73% | 40.63% | 27.27% |
| Average Basic Shares Outstanding | 40.26% | 7.66% | 4.56% | 15.61% | 19.20% |
| Average Diluted Shares Outstanding | 40.26% | 7.66% | 4.56% | 15.61% | 19.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |